Using quick disconnect couplings in fluid handling and
manufacturing operations is the safest way to protect brand
integrity by capturing fluid and product data from point of origin
through point of use, according to a top Colbert...
Many said it couldn't be done, but Australian pharma firm
Phosphagenics has developed what it claims is the world's first
transdermal insulin formulation and has received the first signs
that the product may have blockbuster...
Following a recent report that predicted the use of apes in animal
testing would be unavoidable in the future, Spain could become the
first country worldwide to give some primate species fundamental
rights that are granted to human...
Drug companies have been encouraged by recent studies that suggest
that by blocking the binding of transcription factors may be a way
to short-circuit the harmful effects of diseases.
Researchers believe that the effectiveness of from a commonly used
asthma medicine may be compromised by a gene variation, which is
present in around 13 per cent of the city's population.
CureTech has revealed it has wrapped up a deal in which Teva
Pharmaceuticals will invest $6m (€4.7m) in CureTech, for the
development of a revolutionary cancer drug, based on the company's
potential value of $64m.
According to a new report, key trends that are occurring within
pharma-biotech alliances, as well as within biotech-biotech
alliances, are having to grapple with safety concerns and efficacy,
which have made biotech a high-risk area...
Nanogen introduces its latest enterovirus reagent, which employs
hybridisation technology designed to detect
enteroviruses-associated sequences. Enterovirus infections cause a
wide spectrum of diseases and are the most common cause...
Continuing its aggressive entry into Europe's custom manufacturing
arena, Nicholas Piramal (NPIL) has today acquired Pfizer's
manufacturing facility in Northumberland, in a deal that could earn
it more than $350m (€280m)...
Contract packaging firm Testpak has become the first company to
install production equipment that allows it to make Stora Enso's
prize winning child-resistant and senior friendly packaging.
The first ever monoclonal antibody obtained starting from
transgenic plants with the purpose of purifying a human vaccine has
been registered with Cuban authorities, meaning cigars may not be
the only application the country's...
Biotechnology firm SR Pharma has announced a technical breakthrough
in the formulation of siRNA drugs, enabling them to be stored at
room temperature and reconstituted in one simple step, thus
extending shelf life and making administration...
ClinPhone has launched the first electronic solution for clinical
trials that enables central management of drug accountability
across the entire clinical supply chain, from distribution to
destruction.
A new laboratory test that identifies patients who benefit most
from targeted cancer drugs was the talk of the annual meeting of
the American Society of Clinical Oncology (ASCO) as the test's
accuracy is sure to save hundreds...
The first revisions to the layout of drug package inserts in 25
years will come into effect as of June 30 and the Food and Drug
Administration (FDA) has released a draft technical document to
help drug manufacturers incorporate the...
World-leading clinical research organisation (CRO) Covance has
scored what it says is the biggest contract in its history - a
dedicated space agreement worth a minimum of $187m (€149m).
Fonterra, New Zealand's biggest company, has received a green light
from the European Commission to join with Dutch dairy group Campina
to sell lactose to the pharma industry.
Galapagos are to acquire the drug discovery service operations of
Discovery Partners International for $6.4m in a move that cements
Galapagos' BioFocus division as a top three provider in drug
discovery services worldwide.
BASF has announced it has managed to produce the chemical
intermediate N-ethyldiisoproylamine (EDIPA), also known as Huenig's
base, at a purity of at least 99.5 per cent, helping manufacturers
to stay clear from undesirable side...
Galvanised by the US, thirteen of the EU's major trading partners
have called for a reconsideration of the EU's draft chemicals
legislation, calling it "potentially disruptive" to world
trade.
In the company's largest investment of its kind in Asia,
GlaxoSmithKline (GSK) has decided to build a new vaccine
manufacturing plant in Singapore, as several products in its
pipeline approach commercialisation.
The Cambrex Corporation and Cytori Therapeutics have formed a
collaboration that aims to provide adipose-derived stem cell
products globally for use in basic and translational bioresearch.
Tripos has announced the release of the latest version of its
visualisation platform that allows laboratory scientists to make
better informed decisions based on the three-dimensional molecular
information it produces.
Medical technology company e-pill has unveiled a new automated pill
dispenser which delivers medications at the right time and in the
right amount, ensuring compliance.
Liquid handling specialists Anachem has made available a recycling
programme for the waste polypropylene racks produced by its new
range of high quality robotic tips designed to fit Tecan, Qiagen,
Beckman or Gilson Robotic Platforms.
Invitrogen has formed a collaboration to supply reagents for
Solexa's Genome Analysis System, a sequencing technology that has
the potential to generate over a billion bases of DNA sequence data
per run.
After receiving a grant of $3.9m (€3m) from the US government,
British biotechnology firm Avecia has put together a consortium of
four companies to develop a version of its anthrax vaccine with
increased stability so it works without...
UK firm Domino Printing Sciences has launched a new data print
solution that will allow the late stage customisation of printing
on pharmaceutical packages.
While praising the benefits of radio-frequency identification
(RFID), the US Food and Drug Administration (FDA) has refrained
from demanding its implementation in new measures it unveiled to
combat counterfeit drugs, asking instead...
BioMedica Diagnostic is to open a manufacturing facility in Ghana
that will produce affordable laboratory equipment whilst meeting
the need for a home grown African diagnostic solution for the
Continent's medical problems.
US biotechnology firm Bio-Bridge Science, whose ambition is to
develop an HIV vaccine, has finished major construction of a good
manufacturing practice (GMP) research and manufacturing facility in
Beijing.
TAGSYS have developed two new item-level radio frequency
identification (RFID) readers that it claims will improve
pharmaceutical inventory management.
Outsourcing-Pharma.com focus on: cutting the cost of clinical trials
Outsourcing-Pharma.com sheds some light on how pharma companies can
make sure they are choosing a contract research organisations (CRO)
that will stick to the rules of ethics when running clinical trials
in poorly-regulated countries...
eClinical software and services firm etrials has launched the
latest version of its eDiary technology, which the company claims
will lead to cost savings and increased efficiency in the clinical
trial process.
Biotechnology firm Invitrogen has opened a new facility in New York
which can make its Advanced Granulation Technology (AGT) media
totally free of animal origin components while addressing key
bottlenecks in drug production.
Invitrogen has announced the opening of a new research facility to
be located in Scotland. The decision adds to the investment influx
within the region, which has seen 20 per cent of the UK's biotech
companies set up research...
Pall is organising a free chromatography seminar in Paris this week
presented by leading chromatographers from the pharmaceutical,
biotechnology and biologicals industries.
PerkinElmer has launched a new antibody-free kinase assay
technology that is set to play a major role in drug discovery by
allowing researchers to perform direct measurements of kinase
activities on full-length protein substrates...
Velocity11 has made available globally, a gripper accessory for its
Bravo Liquid Handling Platform that enables a broader range of
fully automated applications to be achieved by the compact Bravo
platform.
Drug delivery firm Egalet has asked SP Medical, a manufacturer of
moulded plastics and coatings, to make sufficient clinical grade
quantities of its therapeutics using injection moulding, which
allows for greater uniformity and reproducibility...
A study that has uncovered core functional differences between a
new oestrogen receptor could form the basis of novel and
potentially more effective treatments of breast cancer as
researchers sought to utilise this therapeutic target.
A membrane protein factory, which represents over half of all known
drug targets could lead to new and improved pharmaceutical
treatments for a broad range of illnesses such as depression, heart
disease, addictions and cystic fibrosis.
Nastech has secured a contract with Procter & Gamble (P&G)
to ramp up manufacturing capacity for a new needle-free drug to
beat osteoporosis, in anticipation of meeting expected global
demand once the product is approved.
Applied Biosystems (AB) make available a wider range of microRNA
assays, expanding the selection to 300 individual assays that are
ideal for cell differentiation, developmental biology, stem cell
and cancer research.
Scientists believe they have made a breakthrough in the fight
against HIV drug resistance by developing a drug that is the first
in a new class of HIV drug candidates called Maturation Inhibitors.
Medical innovations company BTG, continued its progress on the
strategy it implemented last May by revealing its operating
highlights that has seen six new programmes added to its product
pipeline.
AstraZeneca sought to reassure investors this week by providing an
update on progress made in strengthening its product pipeline, a
worry for industry analysts who believe its existing products
cannot underpin earnings growth for...
Contract research company, EpiStem have announced the successful
installation of an automated imaging system that now enables the
firm to expand the range and throughput of its services in
immunohistochemistry (IHC) and histometric...
A new one-step test that is designed to distinguish
heterophile-positive, infectious mononucleosis (IM) from other
common symptomatic infections, claims to deliver a 99 per cent
sensitivity score, significantly improving on current...